Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
EPA watchdog finds nation’s most contaminated sites are vulnerable to flooding, wildfires - 27 Extraordinary Efficiency Applications for Experts
- 3Flu activity in US could continue to rise for weeks, top CDC epidemiologist says
- 4Meet the Stars of the Feline World: Well known Pet Feline Varieties
- 5Defeating An inability to embrace success in Scholarly world: Individual Victories
- A definitive Manual for 2024's Most In vogue Wedding Dresses
- Turkiye’s Erdogan calls Israel’s Somaliland recognition ‘unacceptable’
- Charity 'feels the pinch' of higher energy prices
- No injuries after blast at pro-Israel centre in the Netherlands
- Russia confirms 16 Cameroonian soldiers killed in Ukraine war
- A milestone for Artemis II: Astronauts enter the 'lunar sphere of influence'
- Instructions to Expand Your Smash 1500's Presentation: Tips and Deceives
- The most effective method to Pick the Best Wellbeing Highlights for Seniors in SUVs
- The Most Vital Crossroads in Olympic History
